Regado Biosciences jumps on positive coverage

• Recently-public Regado Biosciences (RGDO) trades 8.7% higher premarket on a bevy of bullish calls.
• Cowen initiates coverage at Outperform.
• Canaccord starts the shares at Buy. Price target is $14.
• BMO weighs in with an Outperform rating and a $12 price target.